Download PDF
Am J Perinatol 2015; 32(03): 289-298
DOI: 10.1055/s-0034-1384642
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

National Trends in Maternal Use of Opioid Drugs among Pregnancy-Related Hospitalizations in the United States, 1998 to 2009

Hamisu M. Salihu
1   Department of Epidemiology and Biostatistics, University of South Florida, College of Public Health, Tampa, Florida
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, College of Medicine, University of South Florida, Tampa, Florida
,
Mulubrhan F. Mogos
1   Department of Epidemiology and Biostatistics, University of South Florida, College of Public Health, Tampa, Florida
,
Abraham A. Salinas-Miranda
1   Department of Epidemiology and Biostatistics, University of South Florida, College of Public Health, Tampa, Florida
,
Jason L. Salemi
1   Department of Epidemiology and Biostatistics, University of South Florida, College of Public Health, Tampa, Florida
,
Valerie E. Whiteman
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, College of Medicine, University of South Florida, Tampa, Florida
› Author Affiliations
Further Information

Publication History

31 January 2014

01 June 2014

Publication Date:
31 July 2014 (online)

    Permissions and Reprints

Abstract

Objective The aim of this study is to describe national trends for opioid use among pregnancy-related hospitalizations from 1998 to 2009.

Study Design Using the Nationwide Inpatient Sample, we identified hospital discharge records associated with the diagnoses codes for the use of opioids for all eligible pregnancy-related inpatient admissions between 1998 and 2009. Joinpoint regression modeling was used to describe changes in trend of pregnancy-related opioid use. The main outcome measure was the annual percent change for opioids use among pregnancy-related hospitalizations.

Results From 1998 to 2009, opioid use was documented in 138,224 of 55,781,966 pregnancy-related inpatient hospitalizations (25 cases per 10,000 discharges). A statistically significant downward trend occurred from 1998 to 2001, whereas from 2002 to 2009 there was a statistically significant upward trend. The increasing trend in opioid use from 2002 to 2009 is notably higher for whites compared with blacks and Hispanics.

Conclusions Our findings highlight the continuous need to monitor opioids use and to revise prescription guidelines, practices, and regulatory mechanisms to curtail the progression of the increasing opioids use during pregnancy. It is critical that health care providers weight the benefits of these medications along with their potential risks when discussing analgesic treatment options with pregnant women.

Keywords

pregnancy - opioids - trends - United States
 

  • References

  • 1 Substance Abuse and Maternal Health Services Adminstartion. Results from the 2011 national survery on drug use and health: summary of national findings. NSDUH Series H-44. Rockville, MD: SAHMSA; 2012
    Google Scholar
  • 2 Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6 (10) 662-672
    CrossrefPubMedGoogle Scholar
  • 3 Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003; 38 (3) 435-445
    CrossrefPubMedGoogle Scholar
  • 4 Manchikanti L, Abdi S, Atluri S , et al; American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician 2012; 15 (3, Suppl): S67-S116
    PubMedGoogle Scholar
  • 5 Manchikanti L, Abdi S, Atluri S , et al; American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I—evidence assessment. Pain Physician 2012; 15 (3, Suppl): S1-S65
    PubMedGoogle Scholar
  • 6 Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002; 18 (4, Suppl): S3-S13
    CrossrefPubMedGoogle Scholar
  • 7 Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008; 11 (2, Suppl): S133-S153
    PubMedGoogle Scholar
  • 8 Kenan K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med 2012; 6 (2) e41-e47
    PubMedGoogle Scholar
  • 9 Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15 (9) 618-627
    CrossrefPubMedGoogle Scholar
  • 10 Manchikanti L, Helm II S, Fellows B , et al. Opioid epidemic in the United States. Pain Physician 2012; 15 (3, Suppl): ES9-ES38
    Google Scholar
  • 11 Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81 (2) 103-107
    CrossrefPubMedGoogle Scholar
  • 12 Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav 2010; 35 (11) 1001-1007
    CrossrefPubMedGoogle Scholar
  • 13 Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis 2010; 29 (2) 245-258
    CrossrefPubMedGoogle Scholar
  • 14 Walhovd KB, Moe V, Slinning K , et al. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 2007; 36 (4) 1331-1344
    CrossrefPubMedGoogle Scholar
  • 15 Fischer G. Treatment of opioid dependence in pregnant women. Addiction 2000; 95 (8) 1141-1144
    CrossrefPubMedGoogle Scholar
  • 16 Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18) 1934-1940
    CrossrefPubMedGoogle Scholar
  • 17 Pan IJ, Yi HY. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008. Matern Child Health J 2013; 17 (4) 667-676
    CrossrefPubMedGoogle Scholar
  • 18 Agency for Healthcare Research and Quality. Health care Cost and Utilization Project (HCUP). Introduction to the NIS:2009, HCUP NIS related reports. Rockville, MD: Agency for Healthcare Research and Quality; 2011
    Google Scholar
  • 19 Merrill CTTH, Owens PLA. Reasons for being admitted to the hospital through the emergency department for children and adolescents, 2004. HCUP Statistical Brief #33. Rockville, MD: Agency for Healthcare Research and Quality; 2007
    Google Scholar
  • 20 Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality. HCUP Quality Control Procedures. Rockville, MD; 2008
    Google Scholar
  • 21 Kassed CA, Levit KR, Hambrick MM. Hospitalizations related to drug abuse, 2005. Statistical Brief #39 Rockville, MD Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality; 2008
    Google Scholar
  • 22 Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19 (3) 335-351
    CrossrefPubMedGoogle Scholar
  • 23 Houchens R, Elixhauser A. Using the HCUP Nationwide Inpatient Sample to Estimate Trends. (Updated for 1988–2004). HCUP Methods Series Report #2006–05 Online: U.S. Agency for Healthcare Research and Quality; 2006
    Google Scholar
  • 24 SAS Institute Inc. SAS/STAT® 9.3 User's Guide. Cary, NC: SAS Institute Inc.; 2011
    Google Scholar
  • 25 Methodology S, Branch A. Joinpoint Regression Program, Version 4.0.1-January 9, 2013. Surveillance Research Program, National Cancer Institute; 2013
    Google Scholar
  • 26 Epstein RA, Bobo WV, Martin PR , et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 2013; 23 (8) 498-503
    CrossrefPubMedGoogle Scholar
  • 27 Chen I, Kurz J, Pasanen M , et al. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med 2005; 20 (7) 593-598
    CrossrefPubMedGoogle Scholar
  • 28 Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med 2011; 9 (3) 219-225
    CrossrefPubMedGoogle Scholar
  • 29 Younger JW, Chu LF, D'Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain 2011; 152 (8) 1803-1810
    Google Scholar
  • 30 Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011; 12 (4) 657-667
    CrossrefPubMedGoogle Scholar
  • 31 Broussard CS, Rasmussen SA, Reefhuis J , et al; National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204 (4) e1-e11
    PubMedGoogle Scholar
  • 32 Joranson DE. Federal and state regulation of opioids. J Pain Symptom Manage 1990; 5 (1, Suppl): S12-S23
    PubMedGoogle Scholar
  • 33 Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage 2002; 23 (2) 138-147
    CrossrefPubMedGoogle Scholar
  • 34 Federation of State Medical Boards of the United States. Model guidelines for the use of controlled substances for the treatment of pain. S D J Med 1999; 52 (1) 25-27
    PubMedGoogle Scholar
  • 35 Center For Substance Abuse Work Group; Federation of State Medical Boards. Model policy guidelines for opioid addiction treatment in the medical office. Pain Physician 2003; 6 (2) 217-221
    PubMedGoogle Scholar
  • 36 Federation of State Medical Boards of the United States, Inc. Model policy for the use of controlled substances for the treatment of pain. J Pain Palliat Care Pharmacother 2005; 19 (2) 73-78
    CrossrefPubMedGoogle Scholar
  • 37 Sandlin D. The new Joint Commission Accreditation of Healthcare Organizations' requirements for pain assessment and treatment: a pain in the assessment?. J Perianesth Nurs 2000; 15 (3) 182-184
    CrossrefPubMedGoogle Scholar
  • 38 Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13 (5) 401-435
    PubMedGoogle Scholar
  • 39 Zhao J, Stockwell T, Macdonald S. Non-response bias in alcohol and drug population surveys. Drug Alcohol Rev 2009; 28 (6) 648-657
    CrossrefPubMedGoogle Scholar